Wegovy Clinical Study Updates

New Evidence Shows 22.8% Weight Loss in Long-term Study The SURMOUNT-4 trial has shown remarkable results for eco-friendly weight management. Our analysis of this Eli lilly GLP1 peptides landmark study reveals that participants lost an impressive 25.3% of their weight with tirzepatide, whereas the placebo group achieved only 9.9%. Maintaining we

read more